Edwin Pan
Obstetrics & Gynecology · Mt Vernon, NYNPI 1467463851
Payments from drug & device makers
Across 410 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Agile Therapeutics, Inc.$1K
- Avion Pharmaceuticals$1K
- Sumitomo Pharma America, Inc.$1K
- Pfizer$451
- Lupin Inc.$373
- plus $2K from 15 others
What the payments were for
- Consulting fees$4205%
- Food & beverage$7,55895%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $2,083 |
| Agile Therapeutics, Inc. | 41 | $1,169 |
| Avion Pharmaceuticals | 108 | $1,151 |
| Sumitomo Pharma America, Inc. | 61 | $1,046 |
| Pfizer | 26 | $451 |
| Lupin Inc. | 12 | $373 |
| Astellas Pharma US Inc | 15 | $305 |
| Exact Sciences | 9 | $267 |
| Myovant Sciences Inc. | 18 | $239 |
| Mayne Pharma Commercial LLC | 13 | $222 |
| Therapeuticsmd, Inc. | 9 | $148 |
| Exeltis, USA Inc. | 2 | $111 |
| Evofem Biosciences, Inc. | 4 | $86 |
| Merck | 4 | $58 |
| Biogen | 3 | $58 |
| Shield Therapeutics Inc | 2 | $51 |
| Scynexis, Inc. | 2 | $50 |
| Hologic Sales And Service, LLC | 2 | $38 |
| Myriad Women's Health, Inc. | 1 | $26 |
| Viiv Healthcare Company | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,978 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 13 | $5,739 |
| Estradiol | 59 | $2,380 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 88 | $1,784 |
| Terconazole | 21 | $722 |
| Betamethasone Dipropionate | 18 | $483 |
| Metronidazole | 15 | $440 |
| ValacyclovirValacyclovir Hcl | 18 | $209 |
| Fluconazole | 29 | $187 |
| Ciprofloxacin Hcl | 14 | $54 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $451 | $5,73913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Other obstetrics & gynecology in Mt Vernon
- Marina FrimerBronx$8.5M
- Nicole NevadunskyBronx$2.5M
- Jin Hee KimNew York$1M
- Carolyn WesthoffNew York$935K
- Mary PolanNew York$862K
- Jessica AtrioBronx$752K
- Mark MartensAuburn$561K
- Steven GoldsteinNew York$557K
- Sharifa FaziliClarence$430K
- Dhruv AgneshwarJohnson City$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.